Sirona Biochem (TSXV:SBM) Total Liabilities : C$3.49 Mil (As of Jan. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Sirona Biochem Total Liabilities?

Sirona Biochem's Total Liabilities for the quarter that ended in Jan. 2024 was C$3.49 Mil.

Sirona Biochem's quarterly Total Liabilities increased from Jul. 2023 (C$2.43 Mil) to Oct. 2023 (C$3.54 Mil) but then declined from Oct. 2023 (C$3.54 Mil) to Jan. 2024 (C$3.49 Mil).

Sirona Biochem's annual Total Liabilities declined from Oct. 2021 (C$1.38 Mil) to Oct. 2022 (C$1.08 Mil) but then increased from Oct. 2022 (C$1.08 Mil) to Oct. 2023 (C$3.54 Mil).

Sirona Biochem Total Liabilities Historical Data

The historical data trend for Sirona Biochem's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem Total Liabilities Chart

Sirona Biochem Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Total Liabilities

Get a 7-Day Free Trial

2.07

2.09

1.38

1.08

3.54

Sirona Biochem Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Liabilities	Get a 7-Day Free Trial															1.13	2.22	2.43	3.54	3.49

Sirona Biochem Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sirona Biochem's Total Liabilities for the fiscal year that ended in Oct. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.867	+	(1.539	+	2.2204460492503E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.137)
	=	3.54

Total Liabilities	=	Total Assets (A: Oct. 2023 )	-	Total Equity (A: Oct. 2023 )
	=	1.032	-	-2.511
	=	3.54

Sirona Biochem's Total Liabilities for the quarter that ended in Jan. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.798	+	(1.556	+	-2.2204460492503E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.139)
	=	3.49

Total Liabilities	=	Total Assets (Q: Jan. 2024 )	-	Total Equity (Q: Jan. 2024 )
	=	0.701	-	-2.792
	=	3.49

Sirona Biochem Total Liabilities Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sirona Biochem (TSXV:SBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (TSXV:SBM) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

SRBCF:USA ZSB:Germany

Address

C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3

Website

https://www.sironabiochem.com

Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.

Executives

Howard Jarman Verrico

Director, Senior Officer